annb0t
Top 20
Opthea Limited
MELBOURNE, Australia, May 25, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr. Megan Baldwin, the Companyâs Chief Executive Officer will present at the Jefferies Healthcare Conference being held at the Marriott Marquis in New York City on June 7-9 2023.
Dr. Baldwin will present on Wednesday, June 7th at 2:00...
>>> Read more: Opthea to Present at the Jefferies 2023 Healthcare Conference
MELBOURNE, Australia, May 25, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr. Megan Baldwin, the Companyâs Chief Executive Officer will present at the Jefferies Healthcare Conference being held at the Marriott Marquis in New York City on June 7-9 2023.
Dr. Baldwin will present on Wednesday, June 7th at 2:00...
>>> Read more: Opthea to Present at the Jefferies 2023 Healthcare Conference
